Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

Abroad (travel likely)Recruiting

Conditions

Liposarcoma · Atypical Lipomatous Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institut du Cancer de Montpellier - Val d'Aurelle, Montpellier, France
Contact: Study coordinator (Marc YCHOU, MD, PhD) · marc.ychou@icm.unicancer.fr · +33467613102

Study leads

Nelly FIRMIN, MD
Study Chair
Institut Régional du Cancer de Montpellier (ICM)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Solid Tumor · Sarcoma · Leiomyosarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Francisco, United States · Boston, United States

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

Metastatic Dedifferentiated Liposarcoma · Metastatic Undifferentiated Pleomorphic Sarcoma · Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Tucson, United States

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Retroperitoneal Liposarcoma

Abroad (travel likely)Recruiting

Atlanta, United States · Boston, United States

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Metastatic Dedifferentiated Liposarcoma · Metastatic Leiomyosarcoma · Metastatic Myxofibrosarcoma

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Los Angeles, United States